A Phase Ib Open-Label Study Evaluating the Safety and Efficacy of NKTR-255 in Combination with CD19-Directed CAR-T Cell Therapy in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Autor: Vinaud Hirayama, Alexandre, Chou, Cassie, Maloney, David G., Marcondes, Mario Q., Turtle, Cameron J.
Zdroj: In Blood 15 November 2022 140 Supplement 1:12747-12748
Databáze: ScienceDirect